Senhwa Biosciences Inc., a clinical stage drug development company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer.
Total raised: $17M
Investors 1
| Date | Name | Website |
| - | WI Harper ... | wiharper.c... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 12.12.2013 | Series B | $17M | - | finsmes.co... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 12.12.2013 | Senhwa Bio... | Senhwa Biosciences Inc., a can... | - | - | sdbj.com/n... |
| 12.12.2013 | Senhwa Bio... | Senhwa Biosciences, Inc., a Ta... | funding S... | - | finsmes.co... |